<< Back to Sponsored Research page
Archived Page
Last Updated: May 8, 2020
For the most up-to-date information and updates related to the COVID-19 pandemic, please visit the Duke Coronvirus Response website.
Some agencies have released specific guidance, while others have not yet. We will keep this site updated with agency guidance as available. Our partners at Harvard maintain an impressive collection of COVID-19 guidance summaries from federal and non-federal sponsors worth referencing.
Agencies
Expenses such as salary support for personnel or nonrefundable conference costs that are budgeted for 2020 may be spent even if your program is disrupted and DDCF will honor its grant commitments and anticipates no disruptions in making scheduled payments
- NIH Extramural Response to Natural Disasters and Other Emergencies
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- UPDATED: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- NIH Guidance on Travel and Meetings
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- NOT-OD-20-083: General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
- Office of Laboratory Animal Welfare (OLAW) Disaster Planning and Response Resources
- Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
- NSF Implementation of OMB Memorandum M-20-20 entitled, “Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19)” dated April 9, 2020
- Revision to NSF’s implementation of OMB Memorandum (M-20-17)
- NSF Guidance on Coronavirus (COVID-19)
- Dear Colleague Letter on the Coronavirus Disease
- Impact on Existing Deadline Dates
- FAQs About the COVID-19 for NSF Proposers and Awardees
- Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19)
- Managing Federal Contract Performance Issues Associated with the Novel Coronavims (COVID-19)
- Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19)